- Home
- MAMA vs AVIR Comparison
MAMA vs AVIR Comparison
Compare MAMA & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAMA | AVIR |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.8M | 236.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | MAMA | AVIR |
|---|---|---|
| Price | $13.76 | $3.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $17.00 | $6.00 |
| AVG Volume (30 Days) | ★ 640.9K | 362.8K |
| Earning Date | 12-08-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.91 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $151,312,000.00 | N/A |
| Revenue This Year | $39.64 | N/A |
| Revenue Next Year | $28.85 | N/A |
| P/E Ratio | $114.33 | ★ N/A |
| Revenue Growth | ★ 29.92 | N/A |
| 52 Week Low | $5.50 | $2.46 |
| 52 Week High | $14.97 | $4.02 |
Technical Indicators
Market Signals| Indicator | MAMA | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 64.51 | 73.01 |
| Support Level | $11.04 | $3.11 |
| Resistance Level | $14.34 | $3.27 |
| Average True Range (ATR) | 0.84 | 0.12 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 66.89 | 88.52 |
Price Performance
Historical ComparisonAbout MAMA Mama's Creations Inc.
Mama's Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).